Cell-Based Assays are laboratory techniques that use living cells to evaluate the biological activity, efficacy, toxicity, or mechanism of action of drugs, biologics, chemicals, or other compounds. Because they measure responses in intact cells, they provide information that is often more physiologically relevant than biochemical (cell-free) assays.
Rising diagnosis rates of narcolepsy
Greater awareness among healthcare providers and patients
Availability of effective prescription therapies
Expansion of sleep medicine centers
Ongoing clinical research into new treatments
Improved access to specialty neurological care
In a buyer-oriented B2B e-commerce model, a company (the buyer) creates an online purchasing environment where approved suppliers can submit quotations, bids, or proposals in response to specific procurement requirements. The focus is on maximizing value for the buyer through competitive sourcing and efficient supplier management.
Camurati-Engelmann Disease (CED) Treatment refers to the medical management of a rare inherited bone disorder characterized by progressive thickening of the long bones and skull. Since there is currently no cure, treatment focuses on relieving symptoms, improving mobility, and managing complications.